UBS raised the firm’s price target on Ares Commercial (ACRE) to $5 from $3.75 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACRE:
- Ares Commercial Real Estate Corp: Sell Rating Amid Challenging Market and Unattractive Valuation
- Ares Commercial Real Estate Reports Strong Q1 2025 Results
- Ares Commercial Real Estate’s Earnings Call Highlights
- Ares Commercial Reports Strong Q1 2025 Financial Results
- Ares Commercial reports Q1 distributable EPS 13c, consensus 7c